Suppr超能文献

Fc受体与免疫球蛋白结合因子。

Fc receptors and immunoglobulin binding factors.

作者信息

Fridman W H

机构信息

Laboratoire d'Immunologie Cellulaire et Clinique, INSERM U.255, Institut Curie, Paris, France.

出版信息

FASEB J. 1991 Sep;5(12):2684-90. doi: 10.1096/fasebj.5.12.1916092.

Abstract

Receptors for the Fc portion of Ig (Fc receptors, FcR) are found on all cell types of the immune system. Three types of FcR react with IgG: Fc gamma RI is a high-affinity receptor binding IgG monomers whereas Fc gamma RII and Fc gamma RIII are low-affinity receptors binding IgG immune complexes; the three types of Fc gamma R are members of the Ig superfamily. Two FcR react with IgE:Fc epsilon RI is a multichain receptor binding IgE with high affinity; it is composed of an IgE-binding alpha chain, homologous to Fc gamma RIII, and of gamma and beta chains that are necessary for receptor expression and signal transduction. The low-affinity Fc epsilon RII is the only FcR described so far that is not a member of the Ig superfamily but resembles animal lectins; it is composed of a transmembrane chain with an intracytoplasmic NH2 terminus. Fc alpha R has homology with Fc gamma R and is a member of the Ig superfamily. Receptors for IgM and IgD are not characterized yet. Finally, Ig transport is made by FcR-like molecules such as the poly-Ig receptor or an MHC-like receptor found on neonatal intestine. A remarkable property of most FcR is the fact that they are released in cell supernatants and circulate in biological fluids as immunoglobulin binding factors (IBF) generated either by cleavage at the cell membrane or by splicing of FcR transmembrane exon. Immunoglobulin binding factors may interfere with Ig-mediated functions and have direct immunoregulatory activities. Involvement of FcR or IBF has been postulated in several diseases, and monoclonal antibodies to FcR are beginning to be used in therapeutics, particularly to target cytotoxic effector lymphocytes and monocytes to tumor cells.

摘要

免疫球蛋白(Ig)Fc段的受体(Fc受体,FcR)存在于免疫系统的所有细胞类型上。三种类型的FcR可与IgG反应:FcγRI是一种高亲和力受体,可结合IgG单体,而FcγRII和FcγRIII是低亲和力受体,可结合IgG免疫复合物;这三种类型的FcγR是Ig超家族的成员。两种FcR可与IgE反应:FcεRI是一种多链受体,可高亲和力结合IgE;它由一条与FcγRIII同源的IgE结合α链以及受体表达和信号转导所必需的γ链和β链组成。低亲和力的FcεRII是迄今为止描述的唯一一种不属于Ig超家族但类似于动物凝集素的FcR;它由一条跨膜链和一个胞质内NH2末端组成。FcαR与FcγR具有同源性,是Ig超家族的成员。IgM和IgD的受体尚未明确。最后,Ig的转运是由FcR样分子完成的,如多聚Ig受体或新生儿肠道中发现的一种MHC样受体。大多数FcR的一个显著特性是它们会释放到细胞上清液中,并作为通过细胞膜切割或FcR跨膜外显子剪接产生的免疫球蛋白结合因子(IBF)在生物体液中循环。免疫球蛋白结合因子可能会干扰Ig介导的功能并具有直接的免疫调节活性。FcR或IBF参与了多种疾病的发生,针对FcR的单克隆抗体已开始用于治疗,特别是将细胞毒性效应淋巴细胞和单核细胞靶向肿瘤细胞。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验